AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / Common Stock - $0.01 Par Value
Symbol
AVNS on NYSE
Shares outstanding
46,382,189
Price per share
$11.23
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
44,941,404
Total reported value
$519,510,585
% of total 13F portfolios
0%
Share change
+177,440
Value change
-$417,928
Number of holders
268
Price from insider filings
$11.23
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $84,851,568 6,826,353 BlackRock, Inc. 31 Mar 2025
T. Rowe Price Investment Management, Inc. 10% +25% $54,487,048 +$11,050,221 4,713,494 +25% T. Rowe Price Investment Management, Inc. 30 Sep 2025
VANGUARD GROUP INC 7.4% -23% $39,595,474 -$12,018,724 3,425,214 -23% The Vanguard Group 30 Sep 2025
RGM Capital, LLC 6.5% $37,122,431 2,986,519 RGM Capital, LLC 31 Dec 2024
ARMISTICE CAPITAL, LLC 5.4% $28,900,000 2,500,000 Armistice Capital, LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 5.1% $27,212,212 2,352,634 Dimensional Fund Advisors LP 30 Sep 2025

As of 30 Sep 2025, 268 institutional investors reported holding 44,941,404 shares of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS). This represents 97% of the company’s total 46,382,189 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 6,833,771 +0.07% 0% $78,998,394
T. Rowe Price Investment Management, Inc. 10% 4,713,494 +18% 0.03% $54,488,000
VANGUARD GROUP INC 7.4% 3,425,214 -23% 0% $39,595,473
ARMISTICE CAPITAL, LLC 5.4% 2,500,000 +23% 0.91% $28,900,000
DIMENSIONAL FUND ADVISORS LP 5.1% 2,352,634 -8.7% 0.01% $27,196,336
BROWN ADVISORY INC 4.8% 2,226,756 +23% 0.03% $25,741,303
STATE STREET CORP 4.1% 1,901,262 -0.85% 0% $21,978,589
D. E. Shaw & Co., Inc. 2.8% 1,299,043 +9% 0.01% $15,016,937
GEODE CAPITAL MANAGEMENT, LLC 2.3% 1,067,524 -0.61% 0% $12,341,359
AQR CAPITAL MANAGEMENT LLC 2% 914,175 +63% 0.01% $10,567,862
MILLENNIUM MANAGEMENT LLC 1.9% 896,242 +312% 0.01% $10,360,558
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.9% 863,950 +30% 0% $9,987,262
MORGAN STANLEY 1.8% 832,497 -3% 0% $9,623,678
CLARK ESTATES INC/NY 1.7% 783,880 +59% 2.1% $9,061,653
Qube Research & Technologies Ltd 1.6% 727,838 +16% 0.01% $8,413,807
AMERIPRISE FINANCIAL INC 1.3% 591,181 +357% 0% $6,834,053
JPMORGAN CHASE & CO 1.2% 577,889 +117% 0% $6,680,397
CITADEL ADVISORS LLC 1.2% 574,104 +195% 0.01% $6,636,642
NORTHERN TRUST CORP 1.1% 492,020 +0.39% 0% $5,687,752
GOLDMAN SACHS GROUP INC 0.98% 453,283 +54% 0% $5,239,952
DIAMOND HILL CAPITAL MANAGEMENT INC 0.94% 434,661 +26% 0.02% $5,024,681
ACADIAN ASSET MANAGEMENT LLC 0.92% 427,157 +63% 0.01% $4,935,000
UBS Group AG 0.83% 384,817 +68% 0% $4,448,484
ExodusPoint Capital Management, LP 0.79% 364,193 -71% 0.06% $4,210,071
Pacer Advisors, Inc. 0.71% 328,805 -31% 0.01% $3,800,986

Institutional Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 155,792 $1,759,687 -$9,732 $11.23 22
2025 Q3 44,941,404 $519,510,585 -$417,928 $11.56 268
2025 Q2 44,711,937 $547,287,477 +$14,185,304 $12.24 279
2025 Q1 43,396,896 $623,273,833 -$6,741,943 $14.33 273
2024 Q4 43,157,780 $687,020,982 +$2,396,640 $15.92 249
2024 Q3 42,712,811 $1,025,954,764 +$11,526,767 $24.03 255
2024 Q2 42,337,644 $843,313,519 -$14,398,612 $19.92 254
2024 Q1 43,127,605 $858,653,821 -$17,705,288 $19.91 253
2023 Q4 1,064,387 $23,887,457 -$1,542,662 $22.44 3
2023 Q3 42,675,960 $864,110,007 -$24,351,631 $20.22 246
2023 Q2 43,338,371 $1,107,946,923 -$10,179,316 $25.56 262
2023 Q1 43,807,502 $1,302,654,864 +$18,319,118 $29.74 274
2022 Q4 43,332,874 $1,172,659,563 +$4,208,294 $27.06 268
2022 Q3 41,174,442 $896,778,990 -$2,876,433 $21.78 208
2022 Q2 43,302,142 $1,183,741,455 -$12,796,001 $27.34 221
2022 Q1 43,597,433 $1,459,505,318 +$751,970 $33.50 247
2021 Q4 42,527,309 $1,474,050,585 -$4,286,665 $34.67 241
2021 Q3 43,174,442 $1,347,034,483 -$24,221,367 $31.20 231
2021 Q2 44,393,089 $1,614,398,015 -$403,606 $36.37 237
2021 Q1 44,075,252 $1,927,606,237 -$43,479,776 $43.74 256
2020 Q4 44,544,788 $2,043,624,874 -$24,499,721 $45.88 230
2020 Q3 45,817,198 $1,522,012,818 -$9,068,541 $33.22 218
2020 Q2 46,191,791 $1,357,497,301 +$22,875,911 $29.39 223
2020 Q1 45,418,842 $1,223,191,553 -$26,043,558 $26.93 210
2019 Q4 45,798,415 $1,543,235,293 +$20,541,409 $33.70 240
2019 Q3 44,985,597 $1,685,153,848 -$4,081,840 $37.46 241
2019 Q2 45,128,299 $1,967,939,754 +$48,054,355 $43.61 267
2019 Q1 44,884,018 $1,915,663,466 +$47,688,023 $42.68 287
2018 Q4 43,754,291 $1,959,620,120 -$16,405,755 $44.79 298
2018 Q3 42,689,133 $2,924,093,350 +$2,852,388,418 $68.50 345
2018 Q2 1,040,878 $59,566,007 +$59,465,007 $57.26 33
2018 Q1 332 $15,299 +$599 $46.08 2
2017 Q4 319 $14,732 $0 $46.18 2
2017 Q3 319 $14,364 -$1,255 $45.03 2
2017 Q2 347 $13,630 $0 $39.28 3
2017 Q1 347 $13,217 -$457 $38.08 3
2016 Q4 359 $13,276 -$2,737 $36.98 3
2016 Q3 432 $14,973 -$1,629 $34.66 2
2016 Q2 479 $15,577 $0 $32.52 2
2016 Q1 611 $19,762 $0 $28.73 3